Recombinant Bifidobacterium longum endo-α-N-acetylgalactosaminidase 101A

Cat. No.: X23-08-YM480

Recombinant Bifidobacterium longum endo-α-N-acetylgalactosaminidase 101A

Synonym: BlNga101A; Endo-α-acetylgalactosaminidase

  • Enzyme Commission Number: 3.2.1.97
Product Size
1 mg; 2 mg; 3 mg; 6 mg
Price
Datasheet
MSDS
Properties
Description
Recombinant Bifidobacterium longum endo-α-N-acetylgalactosaminidase 101A produced by Escherichia coli, functions in catalyzing the release of Gal-1,3-β-GalNAc α-linked to serine or threonine residues of mucin-type glycoproteins.
Expression System
Escherichia coli
Species
Bifidobacterium longum
Concentration
1 mg/mL
Form
Liquid
Purity
≥90%, determined by SDS-PAGE.
Activity
Acetylgalactosaminidases
Buffer
35 mM NaHepes buffer (pH 7.5), 750 mM NaCl, 200 mM imidazole, 3.5 mM CaCl2, and 25% (v/v) glycerol
Applications
Recombinant Bifidobacterium longum endo-α-N-acetylgalactosaminidase 101A can be used in research, biotechnology, and therapeutic interventions. It has the ability to hydrolyze GalNAcα1-pNP, Mucin-type O-glycans.
Storage
Store at -20°C.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0